Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Effects of Taekwondo Match-Simulated Fatigue on Balance Performance in Female Athletes

14. September 2026 aktualisiert von: Berkay Löklüoğlu

Effects of Taekwondo Match-Simulated Fatigue on Static and Dynamic Balance Performance in Female Athletes

Taekwondo is a high-intensity combat sport characterized by repeated explosive kicking actions and rapid changes in body position, requiring well-developed postural control to maintain technical performance and reduce injury risk. Although fatigue has been reported to impair balance performance, previous studies have primarily induced fatigue using non-specific laboratory protocols that do not adequately reflect the physiological and neuromuscular demands of taekwondo competition. Consequently, the effects of taekwondo-specific fatigue on static and dynamic balance performance remain insufficiently understood. The primary objective of this study will be to investigate the effects of a taekwondo match-simulated fatigue protocol on static and dynamic balance performance in female taekwondo athletes. Eighteen competitive female taekwondo athletes will participate in this single-group repeated-measures study. Following a familiarization session, participants will complete a standardized taekwondo match-simulated fatigue protocol consisting of three 2-minute rounds separated by 1-minute passive recovery periods, replicating the official Olympic competition format. Static and dynamic balance performance will be assessed before and immediately after the fatigue protocol using the Biodex Balance System (Biodex Medical Systems Inc., Shirley, NY, USA). Balance performance will be evaluated under static and dynamic testing conditions, and the Overall Stability Index, Anteroposterior Stability Index, and Mediolateral Stability Index will be recorded. The findings of this study are expected to improve understanding of the acute effects of sport-specific fatigue on postural control in female taekwondo athletes and may contribute to the development of evidence-based training and injury prevention strategies.

Studienübersicht

Studientyp

Interventionell

Einschreibung (Tatsächlich)

20

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Female taekwondo athletes aged 18-20 years.
  • Regular participation in taekwondo training (minimum 3 sessions per week).
  • Minimum of 3 years of competitive taekwondo experience.
  • Free from musculoskeletal injury at the time of testing.
  • Willingness to provide written informed consent

Exclusion Criteria:

  • Any musculoskeletal injury within the previous 6 months.
  • Neurological, vestibular, or balance disorders.
  • Lower-extremity surgery within the previous 12 months.
  • Any medical condition preventing participation in maximal exercise.
  • Failure to complete the testing protocol

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Grundlegende Wissenschaft
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Experimental research design
Female taekwondo athletes will complete a standardized taekwondo match-simulated fatigue protocol. Static and dynamic balance performance will be assessed immediately before and after the fatigue protocol during a single experimental session.
Participants will perform a standardized taekwondo match-simulated fatigue protocol designed to reproduce the physiological and neuromuscular demands of an official taekwondo match. Static and dynamic balance performance will be evaluated immediately before and after completion of the protocol.
Static balance performance will be assessed using the Biodex Balance System (Biodex Medical Systems Inc., Shirley, NY, USA). Mean Overall Stability Index (OSI) score, mean Anteroposterior Stability Index (APSI) score, and mean Mediolateral Stability Index (MLSI) score will be calculated automatically by the system. The static balance condition will be combined with an eyes-closed stance with the platform locked at a static level (a fixed support); this condition will designed to reflect support-fixed, vision-deprived postural control, where the participant must maintain postural stability without visual cues on a stable surface.
Dynamic balance performance will be assessed using the Biodex Balance System (Biodex Medical Systems Inc., Shirley, NY, USA). Mean Overall Stability Index (OSI) score, mean Anteroposterior Stability Index (APSI) score, and mean Mediolateral Stability Index (MLSI) score will be calculated automatically by the system. The dynamic balance condition combines an eyes-open stance with the platform stability set to level 5 (an unstable platform that requires active postural adjustments). This condition will be designed to reflect visually guided, mechanically unstable postural control, where the participant must rely on real-time visual feedback to compensate for continuous platform tilt.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Mean Overall Stability Index (OSI) Score
Zeitfenster: Baseline and immediately after the taekwondo match-simulated fatigue protocol.
The Mean Overall Stability Index Score is the arithmetic mean of Overall Stability Index values automatically calculated by the Biodex system at the end of each 20-second single-leg stance trial. This index is a unitless score representing the standard deviation of platform tilt about both the anteroposterior and mediolateral axes combined; it reflects composite postural sway during the trial. Each participant completed the trial barefoot on her dominant lower extremity, under two within-subject conditions: (i) dynamic balance (eyes-open stance with the Biodex platform stability set to level 5), and (ii) static balance (eyes-closed stance with the platform locked at a static level). The index is a unitless score representing the standard deviation of platform tilt about the corresponding axis; the theoretical minimum score is 0, which represents perfect postural stability. There is no fixed theoretical upper limit of these indices. Higher scores indicate poorer balance performance.
Baseline and immediately after the taekwondo match-simulated fatigue protocol.
Mean Mediolateral Stability Index (MLSI) Score
Zeitfenster: Baseline and immediately after the taekwondo match-simulated fatigue protocol.
The Mean Mediolateral Stability Index Score is the arithmetic mean of Mediolateral Stability Index values automatically calculated by the Biodex Balance System at the end of each 20-second single-leg stance trial. This index is a unitless score representing the standard deviation of platform tilt about the frontal axis only; it reflects mediolateral sway and is associated with hip-abductor-driven postural control. Each participant will complete the trial barefoot on her dominant lower extremity (the foot preferred for kicking a ball) under two within-subject conditions: (i) dynamic balance (eyes-open stance with the Biodex platform stability set to level 5), and (ii) static balance (eyes-closed stance with the platform locked at a static level). Theoretically, this index has a minimum value of 0, which represents perfect postural stability; there is no fixed theoretical upper limit. Higher scores indicate poorer balance performance.
Baseline and immediately after the taekwondo match-simulated fatigue protocol.
Mean Anterior-Posterior Stability Index (APSI) Score
Zeitfenster: Baseline and immediately after the taekwondo match-simulated fatigue protocol.
The Mean Anterior-Posterior Stability Index Score is the arithmetic mean of Anterior-Posterior Stability Index values automatically calculated by the Biodex system at the end of each 20-second single-leg stance trial. This index is a unitless score representing the standard deviation of platform tilt about the sagittal axis only; it reflects anteroposterior sway and is associated with the ankle strategy of postural control. Each participant will complete the trial barefoot on her dominant lower extremity (the foot preferred for kicking a ball) under two within-subject conditions: (i) dynamic balance (eyes-open stance with the Biodex platform stability set to level 5), and (ii) static balance (eyes-closed stance with the platform locked at a static level). Theoretically, this index has a minimum value of 0, which represents perfect postural stability; there is no fixed theoretical upper limit. Higher scores indicate poorer balance performance.
Baseline and immediately after the taekwondo match-simulated fatigue protocol.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Mean Age
Zeitfenster: Only baseline.
The mean chronological age of participants at the time of enrollment will be reported in years. Age will be derived from each participant's official identification date of birth and the calendar date of the first balance testing session. It will be used solely as a descriptive baseline demographic variable.
Only baseline.
Mean Body Mass Index
Zeitfenster: Only baseline.
Mean Body Mass Index is the arithmetic mean of participant-level BMI values aggregated from body mass (kg) and height (m) according to the standard formula BMI = body mass (kg) / height² (m²). Body mass will be measured in kilograms and standing height in centimeters by a single trained experimenter during the enrollment session. Each participant-level BMI is therefore a single aggregated value derived from two distinct unit-of-measure measurements; height (centimeters) and body mass (kilograms) are not reported separately. It will be used solely as a descriptive baseline demographic variable.
Only baseline.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Juni 2026

Primärer Abschluss (Tatsächlich)

1. Juli 2026

Studienabschluss (Tatsächlich)

1. August 2026

Studienanmeldedaten

Zuerst eingereicht

25. Juli 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

30. Juli 2026

Zuerst gepostet (Tatsächlich)

5. August 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

14. September 2026

Zuletzt verifiziert

1. August 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 279

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren